Glucose disorders Induced by Tacrolimus on pre Transplantation End-stage renal disease patients

Glucose disorders Induced by Tacrolimus on pre Transplantation End-stage renal disease patients - GLITTER

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2018-001024-19-FR

Enrollment

Registered

2018-06-28

Start date

2018-07-30

Completion date

Unknown

Last updated

2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Trade Name: PROGRAF 0,5 mg Product Name: PROGRAF Pharmaceutical Form: Capsule Trade Name: PROGRAF 1 mg Product Name: PROGRAF Pharmaceutical Form: Capsule Trade Name: PROGRAF 5 mg Product Name: PROGR

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 15 F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range 15

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Main Objective: ;Secondary Objective: ;Primary end point(s):	—

Countries

France

Contacts

Public ContactChloé MOREAU

Centre Hospitalier Départemental Vendée

chloe.moreau@chd-vendee.fr330251446572

Outcome results